Emerging Pharma Leaders Tapped by Pharmaceutical Executive Magazine - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Emerging Pharma Leaders Tapped by Pharmaceutical Executive Magazine



Pharmaceutical Executive, a sister publication of Pharmaceutical Technology,  presented 15 winners in its annual Emerging Pharma Leaders competition in its July issue.

The 15 trendsetters reflect an industry that is changing from Big Pharma to what Pharmaceutical Executive characterizes as growing to be small.

For the first time, we include line executives from generic medicines and vaccines, two adjacent business units which under turbulent market conditions have emerged as key sources of product and process innovation, says Editor William Looney. Several of this year's winners have graduated to new roles that reflect the growing importance the 'c suite' places on knowledge retention, information services and the seeding of skills and talent throughout the organization.”

Other recipients hold positions that reflect the need for active, institutionalized collaboration between the RD and commercial product teams, at the earliest stage of the development cycle,:” Looney adds. And in a business where customer insight is still in short supply, we find more leaders are entering the industry with valuable outside exposure to the fickle affiliations of the retail trade.

The winners can be viewed on the Pharmaceutical Executive website.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here